SALKIND GENE purchased 5.5% of their position (20.24K shares) of UPEXI, INC. on the open market
Open‑market purchase worth $100.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/30/2025ACC: 0001477932-25-005338
Director10% Owner
+220.24K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
220.24K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20.24K
Price / share
$4.94
Trade value
$100K
% of position
5.5%
—
365.13K→385.37K
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
13.0%
—
385.37K→435.37K
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
34.5%
—
435.37K→585.37K
Total
Net shares
+220.24K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +20.24K | $4.94 | $100K | 5.5% | 365.13K | 385.37K |
| Common Stock Direct | — | A · Award | +50K | — | — | 13.0% | 385.37K | 435.37K |
| Common Stock Direct | — | A · Award | +150K | — | — | 34.5% | 435.37K | 585.37K |
| Total | +220.24K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported